Sofia Falkner
HammarskiöldThe ‘outstanding’ Malin von Heideken leads the team at Hammarskiöld, which handles a vast range of issues for its varied client base of generics manufacturers, parallel traders and pharma companies. The practice is well versed in non-contentious matters, including the drafting and negotiation of license and R&D agreements. Von Heideken is noted for her broad experience in representing clients before the Swedish administrative courts in commercial cases against government agencies. Sofia Falkner has a great deal of regulatory expertise, with her primary areas of focus being the pharma and medtech sectors. Falkner also has deep knowledge of Swedish and EU competition law, advising on a number of cartel investigations and the management of internal investigations.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Highly professional, flexible and able to work on a risk-based basis. Not wasting resources while providing excellent advice.’
‘Very knowledgeable within life sciences and related legal matters, high availability and short turnaround times.’
‘Malin von Heideken is an outstanding partner to work with. Very professional in all aspects and high level of availability.’
'Malin von Heideken is a great leader and a brilliant communicator with good common sense and analytical skills.'
Key clients
- Cellcolabs
- Sirona
- Asker Group (OneMed)
- Devyser
- Sigrid
- Psomri
- Orifarm
- EpiEndo Pharmaceuticals
- Norgine
- Althea Group
- Thermo Fisher Scientific
- Tieto
Work highlights
- Advised Sigrid on its clinical programme on SiPore, including legal aspects in relation to clinical studies. Also negotiated clinical study agreements, clinical research organisation agreements, and related services agreements.
- Acted for Orifarm in two Administrative Court cases against the Swedish Medical Products Agency. The team is currently advising Orifarm in relation to one of these cases, which has been appealed to the Supreme Administrative Court.
- Advised Cellcolabs on regulatory issues in relation to marketing and clinical trials. The team has also advised Cellcolabs on the negotiation of a major license agreement.
Lawyers
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Malin von Heideken
HammarskiöldPractice head
The lawyer(s) leading their teams.
Malin von Heideken